Skip to main content

Advertisement

Log in

Temporary Circulatory Support With Ventricular Assist Devices: Update on Surgical and Percutaneous Strategies

  • Cardiogenic Shock: Progress in Mechanical Circulatory Support (JE Rame, Section Editor)
  • Published:
Current Heart Failure Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

The available platforms for temporary circulatory support (TCS) have expanded to include impeller technologies in addition to the traditional approaches with centrifugal pumps and intra-aortic counterpulsation. We review the evidence for competing technologies, relative risk, and benefit of individual TCS platforms and provide a consensus opinion in the context of our institutional experience.

Recent Findings

Trans-aortic axial flow devices (Impella) have significantly impacted the support of patients with cardiogenic shock. Despite the absence of prospective randomized data, the use of both percutaneous and surgical Impella devices is ubiquitous among heart failure centers and rapidly evolving. Extracorporeal centrifugal pumps remain the technology of last resort.

Summary

Despite the increasing use of new TCS platforms, there is little empirical evidence that outcomes have been impacted. Increasingly, systems of care—rather than technology—are seen as the more important variable in the management of patients with cardiogenic shock.

This is a preview of subscription content, log in via an institution to check access.

Access this article

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Impella Ventricular Systems. Instructions for use and clinical reference manual. United States. Document No. 0042-9028rG. 2020.

  2. Impella 5.5 with smartassist for use during cardiogenic shock. Instructions for use and clinical reference manual. United States. Document No. 0550–9002 rA. 2019.

  3. Ramzy D, Soltesz E, Anderson M. New circulatory support system outcomes. ASAIO J, in press. 2020;66:746–52.

    Article  Google Scholar 

  4. Succar L, Sulaica EM, Donahue KR, Wanat MA. Management of anticoagulation with Impella® percutaneous ventricular assist devices and review of new literature. J Thromb Thrombolysis. 2019;48(2):284–91.

    Article  CAS  Google Scholar 

  5. Amin AP, Spertus JA, Curtis JP, Desai N, Masoudi FA, Bach RG, et al. The evolving landscape of Impella use in the United States among patients undergoing percutaneous coronary intervention with mechanical circulatory support. Circulation. 2020;141:273–84. https://doi.org/10.1161/circulationaha.119.044007.

    Article  PubMed  Google Scholar 

  6. O'Neill WW, Grines C, Schreiber T, Moses J, Maini B, Dixon SR, et al. Analysis of outcomes for 15,259 US patients with acute myocardial infarction cardiogenic shock (AMICS) supported with the Impella device. Am Heart J. 2018;202:33–8.

    Article  Google Scholar 

  7. Vetrovec GW, Anderson M, Schreiber T, Popma J, Lombardi W, Maini B, et al. The cVAD registry for percutaneous temporary hemodynamic support: a prospective registry of Impella mechanical circulatory support use in high-risk PCI, cardiogenic shock, and decompensated heart failure. Am Heart J. 2018;199:115–21.

    Article  Google Scholar 

  8. Basir MB, Kapur NK, Patel K, Salam MA, Schreiber T, Kaki A, et al. Improved outcomes associated with the use of shock protocols: Updates from the national cardiogenic shock initiative. Catheter Cardiovasc Interv. 2019;93(7):1173–83. https://doi.org/10.1002/ccd.28307.

    Article  PubMed  Google Scholar 

  9. Bonello L, Delmas C, Gaubert M, Schurtz, Ouattara A, Roubille F. Trials of mechanical circulatory support with percutaneous axial flow pumps in cardiogenic shock complicating acute myocardial infarction: mission impossible? Arch Cardiovasc Dis. 2020. https://doi.org/10.1016/j.acvd.2020.02.001.

  10. Udesen NJ, Moller JE, Lindholm MG, Eiskjer H, Schafer A, Werner N, et al. Rationale and design of DanGer shock: Danish-German cardiogenic shock trial. Am Heart J. 2019;214:60–8. https://doi.org/10.1016/j.ahj.2019.04.019.

    Article  PubMed  Google Scholar 

  11. Cheng R, Tank R, Ramzy D, Azarbal B, Chung J, Esmailian F, et al. Clinical outcomes of Impella microxial devices used to salvage cardiogenic shock as a bridge to durable circulatory support or cardiac transplantation. ASAIO J. 2019;65:642–8.

    Article  Google Scholar 

  12. Seese L, Hickey G, Keebler ME, Mathier MA, Sultan I, Gleason TG, et al. Direct bridging to cardiac transplantation with the surgically implanted Impella 5.0 device. Clin Transpl. 2020;34(3):e13818. https://doi.org/10.1111/ctr.13818.

    Article  Google Scholar 

  13. den Uil CA, Akin S, Jewbali LS, dos Reis MD, Brugts JJ, Constantinescu AA, et al. Short-term mechanical circulatory support as a bridge to durable left ventricular assist device implantation in refractory cardiogenic shock: a systematic review and meta-analysis. Eur J Cardiothorac Surg. 2017;52:14–25.

    Article  Google Scholar 

  14. •• Hernandez-Montfort JA, Xie R, Ton VK, Meyns B, Nakatani T, Yanase M, et al. Longitudinal impact of temporary mechanical circulatory support on durable ventricular assist device outcomes: An IMACS registry propensity matched analysis. J Heart Lung Transplant. 2020;39(2):145–56. https://doi.org/10.1016/j.healun.2019.11.009An extensive discussion of the impact of TCS on subsequent durable LVAD outcome including propensity analysis comparing the hazard of different TCS technologies.

    Article  PubMed  Google Scholar 

  15. Rao P, Khalpey Z, Smith R, Burkhoff D, Kociol RD. Veno-arterial extracorporeal membrane oxygenation for cardiogenic shock and cardiac arrest. Circ Heart Fail. 2018;(9):e004905. https://doi.org/10.1161/CIRCHEARTFAILURE.118.004905.

  16. • Raman J, Alimohamed M, Dobilovic N, Lateef O, Aziz S. A comparison of low and standard anti-coagulation regimens in extracorporeal membrane oxygenation. J Heart Lung Transplant. 2019;38(4):433–9 Anecdotal, but part of a growing literature challenging the role of systemic anticoagulation in patients supported with ECLS/ECMO.

    Article  Google Scholar 

  17. Chung YS, Cho DY, Sohn DS, Lee WS, Won H, Lee DH, et al. Is stopping heparin safe in patients on extracorporeal membrane oxygenation treatment? ASAIO J. 2017;63(1):32–6. https://doi.org/10.1097/MAT.0000000000000442.

    Article  PubMed  Google Scholar 

  18. Russo JJ, Aleksova N, Pitcher I, Couture E, Parlow S, Faraz M, et al. Left ventricular unloading during extracorporeal membrane oxygenation in patients with cardiogenic shock. J Am Coll Cardiol. 2019;73:654–62.

    Article  Google Scholar 

  19. • Meuwese CL, Koudstaal S, Braithwaite S, Hermens JAJ, Donker DW. Left ventricular unloading during extracorporeal membrane oxygenation: Insights from meta-analyzed observational data corrected for confounders. J Am Coll Cardiol. 2019;73(23):3034–5. https://doi.org/10.1016/j.jacc.2019.03.505An interesting discussion of the controversies over mechanical unloading.

    Article  PubMed  Google Scholar 

  20. • Esposito ML, Zhang Y, Qiao X, Reyelt L, Paruchuri V, Schnitzler GR, et al. Left ventricular unloading before reperfusion promotes functional recovery after acute myocardial infarction. J Am Coll Cardiol. 2018;72:501–14. https://doi.org/10.1016/j.jacc.2018.05.034An important basic science study demonstrating the impact of mechanical unloading on initiating a molecular cardio-protective program for subsequent myocardial recovery (enhanced SDF-1a activity).

    Article  PubMed  PubMed Central  Google Scholar 

  21. Vallabhajosyula S, O'Horo JC, Antharam P, et al. Venoarterial extracorporeal membrane oxygenation with concomitant Impella versus venoarterial extracorporeal membrane oxygenation for cardiogenic shock. ASAIO J. 2020;66(5):497–503. https://doi.org/10.1097/MAT.0000000000001039.

    Article  PubMed  Google Scholar 

  22. • Donker DW, Brodie D, JPS H, Broomé M. Left ventricular unloading during veno-arterial ECMO: A simulation study. ASAIO J. 2019;65(1):11–20. https://doi.org/10.1097/MAT.0000000000000755A direct mechanical comparison of the available platforms available to unload the left ventricle.

    Article  PubMed  Google Scholar 

  23. Vallabhajosyula S, O’Horo JC, Antharam P, Ananthaneni S, Vallabhajosyula S, Stulak JM, et al. Concomitant intra-aortic balloon pump use in cardiogenic shock requiring veno-arterial extracorporeal membrane oxygenation: a systematic review and meta-analysis. Circ Cardiovasc Interv. 2018;9. https://doi.org/10.1161/CIRCINTERVENTIONS.118.006930.

  24. Bréchot N, Demondion P, Santi F, et al. Intra-aortic balloon pump protects against hydrostatic pulmonary oedema during peripheral venoarterial-extracorporeal membrane oxygenation. Eur Heart J Acute Cardiovasc Care. 2018;7:62–9.

    Article  Google Scholar 

  25. Kirklin JK, Pagani FD, Goldstein DJ, John R, Rogers JG. American Association for Thoracic Surgery/ International Society for Heart and Lung Transplantation guidelines on selected topics in mechanical circulatory support. J Heart Lung Transplant. 2020;39(3):187–219.

    Article  Google Scholar 

  26. Siriwardena M, Dozois M, Fan E, Billia F. Hemodynamic aspects of veno-arterial extracorporeal membrane oxygenation for cardiac support: a worldwide survey. ASAIO J. 2020;66(5):489–96. https://doi.org/10.1097/MAT.0000000000001024.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Charles Hoopes.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Topical Collection on Cardiogenic Shock: Progress in Mechanical Circulatory Support

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gongora, E., Orozco, E. & Hoopes, C. Temporary Circulatory Support With Ventricular Assist Devices: Update on Surgical and Percutaneous Strategies. Curr Heart Fail Rep 17, 350–356 (2020). https://doi.org/10.1007/s11897-020-00491-x

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11897-020-00491-x

Keywords

Navigation